What is TIPS (Transjugular Intrahepatic Portosystemic Shunt)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Transjugular Intrahepatic Portosystemic Shunt (TIPS)

TIPS is an interventional procedure that creates a bypass within the liver by placing a metal stent between the portal and hepatic veins, reducing portal pressure to treat complications of portal hypertension such as refractory variceal bleeding and ascites. 1

Procedure Details

  • TIPS is performed by an interventional radiologist or hepatologist who inserts a wire through the jugular vein in the neck, then threads it through the liver under X-ray guidance to create a connection between the portal and hepatic veins 1
  • The procedure typically takes 90-120 minutes and is performed under general anesthesia or deep sedation 1
  • Covered stents are preferred over bare metal stents due to superior patency rates 2
  • The stent creates a direct pathway for blood to flow from the portal vein to the hepatic vein, effectively bypassing the liver and reducing portal pressure 1

Main Indications

  • Acute variceal bleeding unresponsive to standard treatments (endoscopic banding and drug therapy) 1, 3
  • Prevention of variceal rebleeding in patients who have bled again despite standard endoscopic and medical therapies 1, 2
  • Refractory or recurrent ascites where fluid accumulation persists despite paracentesis or diuretics 1, 3, 2
  • Hepatic hydrothorax unresponsive to conventional therapy 1, 3
  • Budd-Chiari syndrome in selected patients at specialist centers that also offer liver transplantation 1
  • Portal vein thrombosis in selected patients at specialized centers 1, 2
  • Bridge to liver transplantation in patients with end-stage liver disease and complications of portal hypertension 4, 5

Pre-Procedure Evaluation

  • Comprehensive pre-procedure assessment includes:
    • Specialized imaging of the liver and surrounding vessels 1
    • Liver and kidney function tests 1
    • Coagulation studies 1
    • Cardiac function assessment 1
    • Nutritional assessment 1
    • Evaluation of encephalopathy risk 1

Contraindications

  • Bilirubin >50 μmol/L 3, 2
  • Platelets <75×10^9 3, 2
  • Pre-existing encephalopathy 3, 2
  • Active infection 3, 2
  • Severe cardiac failure 3, 2
  • Severe pulmonary hypertension 3, 2
  • Porto-pulmonary hypertension requires careful evaluation as TIPS may worsen this condition 3

Complications

  • Short-term complications (occur in <5% of patients):

    • Bleeding 1, 2
    • Infection 1, 2
    • Heart failure 1, 2
    • Liver failure 1, 2
    • Kidney failure 1, 2
    • Fever 1
    • Damage to blood vessels and bile ducts 1
  • Long-term complications:

    • Hepatic encephalopathy affects approximately one-third of patients 1, 3, 2, 4
    • Shunt dysfunction requiring revision (67.5% in first year, 38% in second year, 24.4% in third year) 5
    • Potential for overshunting leading to hepatic decompensation 6

Post-Procedure Monitoring

  • Doppler ultrasound is recommended:
    • One week after TIPS implantation in patients with prothrombotic conditions 2
    • Regular follow-up at 6-12 month intervals 2
    • When shunt insufficiency is suspected (blood flow velocity within stent <50 cm/s) 5

Special Considerations

  • Centers performing TIPS should handle a minimum of 10 cases annually, with complex cases reserved for centers doing at least 20 cases per year 1
  • In cases of overshunting complications, TIPS reduction techniques can be considered before complete occlusion 6
  • The role of early or pre-emptive TIPS (within 72 hours of stabilized acute variceal bleeding) remains under investigation, particularly in high-risk patients (Child's C disease or MELD ≥19) 1, 3, 2
  • TIPS can be particularly valuable in liver transplant candidates to minimize complications of portal hypertension during the waiting period 4, 5
  • TIPS in liver transplant recipients (for recurrent portal hypertension) is associated with lower clinical response rates and higher complications compared to non-transplant patients 7

Management of TIPS Complications

  • Hepatic encephalopathy usually responds to simple measures and medical therapy, but in severe cases, it may be necessary to reduce the diameter of or occlude the TIPS 3
  • TIPS revision is effective in maintaining sufficient reduction of the portosystemic pressure gradient when shunt dysfunction occurs 5

References

Guideline

TIPS Procedure and Indications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Portal Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Portal Hypertension Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: results in 85 patients.

Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 1996

Research

Transjugular Intrahepatic Portosystemic Shunt Reduction Techniques.

Seminars in interventional radiology, 2023

Research

Transjugular intrahepatic portosystemic shunts in liver transplant recipients.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.